Product Name:5-Fluorooxindole

IUPAC Name:5-fluoro-2,3-dihydro-1H-indol-2-one

CAS:56341-41-4
Molecular Formula:C8H6FNO
Purity:95%+
Catalog Number:CM148054
Molecular Weight:151.14

Packing Unit Available Stock Price($) Quantity
CM148054-100g in stock ƈŤǙ
CM148054-500g in stock ƿŤŗ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:56341-41-4
Molecular Formula:C8H6FNO
Melting Point:-
Smiles Code:C1=C2C(=CC=C1F)NC(=O)C2
Density:
Catalog Number:CM148054
Molecular Weight:151.14
Boiling Point:307.2°C at 760 mmHg
MDL No:MFCD02179598
Storage:Keep in a tight container and store at ambient temperature

Category Infos

Indolinones
Indolinone derivatives have in common the presence of a hydrogen bond between the C-2 carbonyl and a hydrogen donor in a side chain, generally a pyrrole ring. Indolinone displays very promising antitumor properties by inhibiting various kinase families.

Column Infos

Vorolanib
EyePoint Pharmaceuticals announced on December 4th announced positive topline results of its Phase 2 DAVIO 2 trial of EYP-1901, an investigational sustained delivery maintenance treatment for wet age-related macular degeneration (wet AMD) combining vorolanib, a selective tyrosine kinase inhibitor with bioerodible Durasert E™. Vorolanib brings a new mechanistic approach to the treatment of VEGF-mediated retinal diseases as a pan-VEGF receptor blocker, blocking all VEGF isoforms. Vorolanib features reduced off-target binding and at clinically relevant doses does not inhibit Tie-2, a critical pathway associated with vascular stability, which may result in an improved efficacy. Further, in an in-vivo model of retinal detachment, vorolanib demonstrated neuroprotection, and potential antifibrotic benefits.